Decrease in IL-4 measured by standard ELISA. حسب Albert S. Jun (231619)

"…Each ELISA value is an average of two measurements. The decrease in IL-4 in the keratoconus pool (7.6±5 pg/ml), compared to controls (14.2±8.6 pg/ml) was statistically significant (p≤0.05, Mann-Whitney test). …"

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. حسب Mengli Zhang (6331172)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. حسب Xiaojuan Li (351842)

ROS and superoxide decrease in the dormant form of mycobacteria. حسب Amar Yeware (7115063)

Decrease in CLPs, NKPS and Block in NKP progression. حسب John Richards (53768)

Adhesion strength is decreased in NEDD9−/− MEFs. حسب Jessie Zhong (171961)

Decrease of myopia progression with 0.025% atropine حسب Celso Marcelo da Cunha (4894324)

IR decreases but does not arrest ATC growth. حسب Vlad C. Sandulache (515406)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. حسب Immacolata Castellano (603814)

Multiple miRNAs decrease telomerase activity. حسب Radmila Hrdličková (523455)

Knockdown of p65 in A549 cells results in a decreased infection rate. حسب Janine J. Wilden (8849948)

Decreased H4R expression in GCs. حسب Chao Zhang (51048)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. حسب Yuting Qin (1950118)

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). حسب Ki Hwan Kim (427869)

Deletion of the 55C <i>Bom</i> genes impairs resistance to <i>E</i>. <i>faecalis</i> infection rather than tolerance. حسب Alexa W. Clemmons (247908)

MES transiently decreases mitochondrial membrane potential. حسب Shingo Matsuyama (672132)

GSH content was decreased in low glucose conditions. حسب Martine Emery (215947)

B2 decreases glycolytic intermediates in cells. حسب Craig Eyster (392633)

"…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …"

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. حسب Barbara Blouw (715467)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. حسب Ulf Schulze-Topphoff (174453)

"…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …"